Meadpoint breaks ground with GroundSwell

Meadpoint breaks ground with GroundSwell

/* Style Definitions */

span.prnews_span

{

font-size:8pt;

font-family:"Arial";

color:black;

}

a.prnews_a

{

color:blue;

}

li.prnews_li

{

font-size:8pt;

font-family:"Arial";

color:black;

}

p.prnews_p

{

font-size:0.62em;

font-family:"Arial";

color:black;

margin:"0in";

}

Meadpoint breaks ground with GroundSwell

PR Newswire

DENVER, March 27, 2013

DENVER, March 27, 2013 /PRNewswire/ -- Meadpoint Venture Partners, Inc., the exclusive licensee and distributor of FusionPharm's (OTC Pink: FSPM) patent pending PharmPods™ High Intensity container based hydroponic cultivation system (www.pharmpods.com), today announced that it has entered into an LOI with GroundSwell Cannabis Boutique (www.groundswelldenver.com), Denver's premier medical cannabis dispensary and infused products provider. GroundSwell is currently utilizing the PharmPod H.I. containers and plans to exclusively utilize the superior cultivation technology in all of its future expansion. Don Novak of Groundswell is quoted as stating, "The PharmPod High Intensity container system achieves outstanding results. This superior system is a game changer and is an instrumental factor in our plans for regional and national expansion."

About Meadpoint Venture Partners. 

Meadpoint Venture Partners is the exclusive licensee and distributor of the FusionPharm High Intensity container cultivation system. Meadpoint is currently conducting a multistate sales campaign to show industry professionals the potential of HI containers as an effective and economical medium for the cultivation of fruiting and flowing plants in a high-growth industry.  

About GroundSwell 

GroundSwell Cannabis Boutique is a professional, high-quality, full-service medical cannabis center and infused products manufacturer with a patient-centric approach to dispensing the highest quality medicine. They pride themselves on providing a unique, friendly and welcoming environment for all patients, with a knowledgeable staff that cares about your needs.

About FusionPharm Inc. (FSPM)

FusionPharm, Inc. was organized to capitalize on opportunities present in the rapidly growing the $26 billion natural food and specialty herb market. FusionPharm's primary focus is the development and deployment of the patent pending PharmPods^™ advanced hydroponic cultivation systems. PharmPods are constructed from standard ISO steel shipping containers that are repurposed for use in indoor plant cultivation. Using advanced lighting technology, cutting edge growing media and proprietary cultivation techniques, a single PharmPod is capable of growing more produce than one full acre of traditional agriculture in less than half the time using 90% less water than traditional agriculture and no harmful pesticides or herbicides.

NOTES ABOUT FORWARD-LOOKING STATEMENTS: Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company's Securities and Exchange Commission reports and filings. Certain statements contained in this release that are not historical facts constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, and are intended to be covered by the safe harbors created by that Act. Reliance should not be placed on forward-looking statements because they involve unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward-looking statements may be identified by words such as estimates, anticipates, projects, plans, expects, intends, believes, should and similar expressions and by the context in which they are used. Such statements are based upon current expectations of the Company and speak only as of the date made. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which they are made.

Contact:
Meadpoint Venture Partners 

[e-mail]

SOURCE Meadpoint Venture Partners